Course of Adverse Events during Short Treatment Regimen in Patients with Rifampicin-Resistant Tuberculosis in Burundi

Course of Adverse Events during Short Treatment Regimen in Patients with Rifampicin-Resistant Tuberculosis in Burundi

The introduction of the nine-month short-treatment regimen (STR) has drastically improved outcomes of rifampicin-resistant tuberculosis (RR-TB) treatment. Adverse events (AE) commonly occur, including injectable-induced hearing loss. In Burundi we retrospectively assessed the frequency of adverse ev...

Full description

Bibliographic Details
Main Authors: François Ciza, Tinne Gils, Michel Sawadogo, Tom Decroo, Alberto Roggi, Alberto Piubello, Nimer Ortuño-Gutiérrez
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Journal of Clinical Medicine
Subjects:
multi-drug-resistant tuberculosis
short treatment regimen
Burundi
Online Access:https://www.mdpi.com/2077-0383/9/6/1873

Similar Items

Similar Items